Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Isacson

Showing results (61-70 of 140) with videos related to

Pageof 14
Sort By:
Cell Reports|June 10, 2014
Long-term health of dopaminergic neuron transplants in Parkinson's disease patientsPenelope J Hallett, Oliver Cooper, Damaso Sadi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2020
Cell type-specific lipid storage changes in Parkinson's disease patient brains are recapitulated by experimental glycolipid disturbanceOeystein Roed Brekk, Jonathan R Honey, Seungil Lee, et al.
Neurobiology of Disease|May 3, 2012
α-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficitsPenelope J Hallett, Jesse R McLean, Andrew Kartunen, et al.
Hippocampus|January 31, 2004
Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndromeAnn-Charlotte Granholm, Linda Sanders, Hyemyung Seo, et al.
Stem Cells (Dayton, Ohio)|June 26, 2007
Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populationsJan Pruszak, Kai-Christian Sonntag, Moe Hein Aung, et al.
Neurobiology of Disease|August 28, 2018
The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stressElizabeth B Moloney, Alyssa Moskites, Eliza J Ferrari, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 3, 2010
The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degenerationMichela Deleidi, Penelope J Hallett, James B Koprich, et al.
Neuroscience Letters|July 4, 2002
Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's diseaseKevin St P McNaught, Roger Belizaire, Peter Jenner, et al.
Journal of Neuroinflammation|August 3, 2004
Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's diseaseRosario Sánchez-Pernaute, Andrew Ferree, Oliver Cooper, et al.
Human Molecular Genetics|May 13, 2005
Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protectionChee Yeun Chung, Hyemyung Seo, Kai Christian Sonntag, et al.
Pageof 14

Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
Cell Reports|June 10, 2014
Long-term health of dopaminergic neuron transplants in Parkinson's disease patientsPenelope J Hallett, Oliver Cooper, Damaso Sadi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2020
Cell type-specific lipid storage changes in Parkinson's disease patient brains are recapitulated by experimental glycolipid disturbanceOeystein Roed Brekk, Jonathan R Honey, Seungil Lee, et al.
Neurobiology of Disease|May 3, 2012
α-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficitsPenelope J Hallett, Jesse R McLean, Andrew Kartunen, et al.
Hippocampus|January 31, 2004
Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndromeAnn-Charlotte Granholm, Linda Sanders, Hyemyung Seo, et al.
Stem Cells (Dayton, Ohio)|June 26, 2007
Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populationsJan Pruszak, Kai-Christian Sonntag, Moe Hein Aung, et al.
Neurobiology of Disease|August 28, 2018
The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stressElizabeth B Moloney, Alyssa Moskites, Eliza J Ferrari, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 3, 2010
The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degenerationMichela Deleidi, Penelope J Hallett, James B Koprich, et al.
Neuroscience Letters|July 4, 2002
Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's diseaseKevin St P McNaught, Roger Belizaire, Peter Jenner, et al.
Journal of Neuroinflammation|August 3, 2004
Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's diseaseRosario Sánchez-Pernaute, Andrew Ferree, Oliver Cooper, et al.
Human Molecular Genetics|May 13, 2005
Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protectionChee Yeun Chung, Hyemyung Seo, Kai Christian Sonntag, et al.
Pageof 14